• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桡骨茎突狭窄性腱鞘炎的治疗。一项关于注射类固醇和使用夹板固定效果的前瞻性研究。

Treatment of de Quervain tenosynovitis. A prospective study of the results of injection of steroids and immobilization in a splint.

作者信息

Witt J, Pess G, Gelberman R H

机构信息

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, 02114.

出版信息

J Bone Joint Surg Am. 1991 Feb;73(2):219-22.

PMID:1993717
Abstract

In a prospective study of non-operative treatment of de Quervain tenosynovitis, ninety-nine wrists of ninety-five consecutively seen patients who had this diagnosis had an injection of one milliliter of a 1 per cent lidocaine solution and one milliliter of a suspension containing forty milligrams of methylprednisolone acetate. Twelve patients (twelve wrists) were lost to follow-up. Of the remaining eighty-seven wrists, fifty-four (62 per cent) had a satisfactory outcome at a mean of eighteen months (minimum follow-up, twelve months). The duration of symptoms before treatment did not affect the outcome. The result in thirty-three wrists (38 per cent) was considered unsatisfactory. Thirty of these wrists were subsequently treated with operative release of the first dorsal compartment, and twenty-two (73 per cent) of the thirty were found to have a separate compartment for the extensor pollicis brevis. The prevalence of a separate compartment is significantly higher than that in the general population, as shown in anatomical studies of cadavera.

摘要

在一项关于桡骨茎突狭窄性腱鞘炎非手术治疗的前瞻性研究中,95例连续就诊且确诊为此病的患者共99个腕关节接受了1毫升1%利多卡因溶液和1毫升含40毫克醋酸甲基泼尼松龙混悬液的注射治疗。12例患者(12个腕关节)失访。在其余87个腕关节中,54个(62%)在平均18个月(最短随访12个月)时获得了满意的结果。治疗前症状持续时间不影响治疗结果。33个腕关节(38%)的结果被认为不满意。其中30个腕关节随后接受了第一背侧腱鞘切开减压术治疗,30个中有22个(73%)发现拇短伸肌有一个独立的腱鞘。如尸体解剖学研究所示,独立腱鞘的发生率显著高于普通人群。

相似文献

1
Treatment of de Quervain tenosynovitis. A prospective study of the results of injection of steroids and immobilization in a splint.桡骨茎突狭窄性腱鞘炎的治疗。一项关于注射类固醇和使用夹板固定效果的前瞻性研究。
J Bone Joint Surg Am. 1991 Feb;73(2):219-22.
2
Treatment of de Quervain's disease.桡骨茎突狭窄性腱鞘炎的治疗。
J Hand Surg Am. 1994 Jul;19(4):595-8. doi: 10.1016/0363-5023(94)90262-3.
3
Anatomical variations in the first extensor compartment of the wrist. A clinical and anatomical study.腕关节第一伸肌间室的解剖变异:一项临床与解剖学研究
J Bone Joint Surg Am. 1986 Jul;68(6):923-6.
4
Methylprednisolone acetate injection plus casting versus casting alone for the treatment of de Quervain's tenosynovitis.醋酸甲泼尼龙注射加固定与单纯固定治疗桡骨茎突狭窄性腱鞘炎。
Arch Iran Med. 2010 Jul;13(4):270-4.
5
Stenosing tenosynovitis of the fingers and thumb. Results of a prospective trial of steroid injection and splinting.
Clin Orthop Relat Res. 1984 Nov(190):236-8.
6
Extensor triggering in de Quervain's stenosing tenosynovitis.桡骨茎突狭窄性腱鞘炎中的伸肌弹响
J Hand Surg Am. 1999 Nov;24(6):1311-4. doi: 10.1053/jhsu.1999.1311.
7
Suprafibrous injection with corticosteroid in de Quervain's disease.
J Med Assoc Thai. 2003 Mar;86(3):232-7.
8
Prevalence of a Septated First Dorsal Compartment Among Patients With and Without De Quervain Tenosynovitis: An In Vivo Anatomical Study.患与未患桡骨茎突狭窄性腱鞘炎患者中第一背侧间隔存在分隔的患病率:一项活体解剖学研究
Hand (N Y). 2020 May;15(3):348-352. doi: 10.1177/1558944718810864. Epub 2018 Nov 15.
9
De Quervain's disease: surgical or nonsurgical treatment.
J Hand Surg Am. 1990 Jan;15(1):83-7. doi: 10.1016/s0363-5023(09)91110-8.
10
De Quervain tendinopathy: survivorship and prognostic indicators of recurrence following a single corticosteroid injection.德·奎尔万腱鞘炎:单次皮质类固醇注射后的生存率及复发预后指标
J Hand Surg Am. 2015 Jun;40(6):1161-5. doi: 10.1016/j.jhsa.2014.12.027. Epub 2015 Apr 30.

引用本文的文献

1
Comparative Analysis of Ultrasound and Surgical Findings in Anatomical Variations of de Quervain's Disease.超声与手术所见在桡骨茎突狭窄性腱鞘炎解剖变异中的对比分析
Clin Orthop Surg. 2025 Apr;17(2):308-316. doi: 10.4055/cios24127. Epub 2025 Mar 14.
2
De Quervain Tendinopathy: Anatomical Prognostic Indicators of Corticosteroid Injection Success.德·奎尔万腱鞘炎:皮质类固醇注射成功的解剖学预后指标
J Pers Med. 2024 Aug 31;14(9):928. doi: 10.3390/jpm14090928.
3
Efficacy of Ultrasound-Guided Hydrodissection for Treating De Quervain's Tenosynovitis.
超声引导下水分离术治疗桡骨茎突狭窄性腱鞘炎的疗效
JPRAS Open. 2024 Jun 8;41:148-158. doi: 10.1016/j.jpra.2024.06.002. eCollection 2024 Sep.
4
Clinical Considerations of First Extensor Wrist Compartment (FEWC) Variants and De Quervain's Disease: A Review Study.第一伸腕肌间隔(FEWC)变异与桡骨茎突狭窄性腱鞘炎的临床考量:一项综述研究
Cureus. 2023 Jul 19;15(7):e42124. doi: 10.7759/cureus.42124. eCollection 2023 Jul.
5
Development of de Quervain Tenosynovitis After Distal Radius Fracture.桡骨远端骨折后发生的 De Quervain 腱鞘炎。
Hand (N Y). 2024 Oct;19(7):1154-1158. doi: 10.1177/15589447231174042. Epub 2023 May 28.
6
de Quervain's Disease among Patients Visiting the Orthopaedic Outpatient Department of Tertiary Care Center: A Descriptive Cross- sectional Study.德奎文氏病患者在三级保健中心骨科门诊就诊:描述性横断面研究。
JNMA J Nepal Med Assoc. 2023 Jan 1;61(257):68-71. doi: 10.31729/jnma.7947.
7
Anatomical Variations of the First Dorsal Compartment in de Quervain Tenosynovitis.De Quervain 腱鞘炎中第一背侧间隔的解剖变异。
Hand (N Y). 2024 Oct;19(7):1159-1165. doi: 10.1177/15589447231164746. Epub 2023 Apr 19.
8
De Quervain's tenosynovitis: a non-randomized two-armed study comparing ultrasound-guided steroid injection with surgical release.德奎文氏腱鞘炎:一项比较超声引导下类固醇注射与手术松解的非随机双臂研究。
Musculoskelet Surg. 2023 Mar;107(1):105-114. doi: 10.1007/s12306-022-00735-0. Epub 2022 Feb 23.
9
Type II de Quervain's disease: depicting subcompartmentalisation with ultrasound.Ⅱ型桡骨茎突狭窄性腱鞘炎:超声显示亚区域划分
BMJ Case Rep. 2021 Jun 21;14(6):e242173. doi: 10.1136/bcr-2021-242173.
10
Comparison between acupotomy and local steroid injection for the management of de Quervain disease: A systematic review protocol.针刀与局部注射类固醇治疗桡骨茎突狭窄性腱鞘炎的比较:一项系统评价方案。
Medicine (Baltimore). 2019 Nov;98(46):e17765. doi: 10.1097/MD.0000000000017765.